BioCentury | Apr 13, 2009
Clinical News
TerbiMed: Phase II data
...MedPharm said a short dosing regimen of TerbiMed met the primary endpoint of non-inferiority to Lamisil...
...Switzerland) markets Lamisil to treat onychomycosis and tinea capitis. MedPharm Ltd. , Charlbury, U.K. Product: TerbiMed...
...Molecular target: Not applicable Description: Dry, transparent film of terbinafine applied on the skin using MedSpray...
...Switzerland) markets Lamisil to treat onychomycosis and tinea capitis. MedPharm Ltd. , Charlbury, U.K. Product: TerbiMed...
...Molecular target: Not applicable Description: Dry, transparent film of terbinafine applied on the skin using MedSpray...